Janney Capital Management LLC lessened its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 33,983 shares of the conglomerate’s stock after selling 1,323 shares during the quarter. Janney Capital Management LLC’s holdings in Danaher were worth $7,801,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in DHR. Daymark Wealth Partners LLC lifted its stake in shares of Danaher by 0.9% during the 4th quarter. Daymark Wealth Partners LLC now owns 17,521 shares of the conglomerate’s stock valued at $4,022,000 after buying an additional 155 shares in the last quarter. Albion Financial Group UT boosted its position in shares of Danaher by 360.7% during the 4th quarter. Albion Financial Group UT now owns 1,290 shares of the conglomerate’s stock valued at $296,000 after acquiring an additional 1,010 shares during the last quarter. Beaumont Financial Advisors LLC grew its position in Danaher by 59.4% in the fourth quarter. Beaumont Financial Advisors LLC now owns 2,958 shares of the conglomerate’s stock worth $679,000 after acquiring an additional 1,102 shares in the last quarter. Bourgeon Capital Management LLC boosted its stake in Danaher by 7.4% during the fourth quarter. Bourgeon Capital Management LLC now owns 60,178 shares of the conglomerate’s stock worth $13,814,000 after buying an additional 4,150 shares during the period. Finally, Roberts Wealth Advisors LLC grew its stake in shares of Danaher by 18.8% during the fourth quarter. Roberts Wealth Advisors LLC now owns 950 shares of the conglomerate’s stock valued at $226,000 after buying an additional 150 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
Several analysts have recently weighed in on the stock. Royal Bank of Canada decreased their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Raymond James cut their price target on Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research report on Tuesday. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a report on Thursday, October 31st. Finally, Evercore ISI lifted their price target on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $285.55.
Danaher Price Performance
NYSE:DHR opened at $243.99 on Wednesday. The company has a market capitalization of $176.23 billion, a P/E ratio of 46.53, a P/E/G ratio of 4.30 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a 52 week low of $225.42 and a 52 week high of $281.70. The stock’s fifty day moving average is $234.84 and its two-hundred day moving average is $253.53.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the firm posted $2.02 earnings per share. Danaher’s revenue was up 3.1% compared to the same quarter last year. Equities analysts expect that Danaher Co. will post 7.49 EPS for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- What Investors Need to Know About Upcoming IPOs
- Tempus AI: A Game-Changer in AI-Powered Healthcare
- Stock Market Upgrades: What Are They?
- Pelosi Bets Big on AI: This Is What You Need to Know
- How to trade using analyst ratings
- Mobileye’s High Short Interest Signals Squeeze Potential
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.